Importance of clustered 2′-O-(2-aminoethyl) residues for the gene targeting activity of triple helix-forming oligonucleotides

被引:39
|
作者
Puri, N
Majumdar, A
Cuenoud, B
Miller, PS
Seidman, MM
机构
[1] NIA, LMG, NIH, Baltimore, MD 21224 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA
[3] Novartis Pharmaceut Ltd, CH-4002 Basel, Switzerland
关键词
D O I
10.1021/bi035808l
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We are developing triple helix-forming oligonucleotides (TFOs) as gene targeting reagents in living mammalian cells. We have described psoralen-linked TFOs with 2'-O-methyl and 2'-O-(2-aminoethyl) (2'-AE) substitutions that are active in a gene knockout assay in cultured cells. The assay is based on mutagenesis by psoralen, a photoactive DNA cross-linker. Previous work showed that TFOs with three or four 2'-AE residues were disproportionately more active than those with one or two substitutions. Here we demonstrate that for optimal bioactivity the 2'-AE residues must be clustered rather than dispersed. We have further characterized bioactive and inactive TFOs in an effort to identify biochemical and biophysical correlates of biological activity. While thermal stability is a standard monitor of TFO biophysical activity, we find that T-m values do not distinguish bioactive and inactive TFOs. In contrast, measurements of TFO association rates appear to correlate well with bioactivity, in that triplex formation occurs disproportionately faster with the TFOs containing three or four 2'-AE residues. We asked if extending the incubation time prior to photoactivation would enhance the bioactivity of a TFO with a slow on rate relative to the TFO with a faster association rate. However, there was no change in bioactivity differential. These results are compatible with a model in which TFO binding in vivo is followed by relatively rapid elution by cellular functions, similar to that described for transcription factors. Under these circumstances, TFOs with faster on rates would be favored because they would be more likely to be in triplexes at the time of photoactivation.
引用
收藏
页码:1343 / 1351
页数:9
相关论文
共 50 条
  • [21] Selective inhibition of monocyte chemoattractant protein-1 gene expression in human embryonal kidney cells by specific triple helix-forming oligonucleotides
    Marchand, P
    Resch, K
    Radeke, HH
    JOURNAL OF IMMUNOLOGY, 2000, 164 (04): : 2070 - 2076
  • [22] Targeted gene knockouts in mammalian cell cultures by 2′-O-aminoethyl-modified triplex forming oligonucleotides.
    Puri, N
    Majumdar, A
    Cuenoud, B
    Natt, F
    Martin, P
    Miller, PS
    Seidman, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U163 - U163
  • [23] Reduction of mdr1 gene amplification in human multidrug-resistant LoVo DX cell line is promoted by triple helix-forming oligonucleotides
    Morassutti, C
    Scaggiante, B
    Xodo, LE
    Dapas, B
    Paroni, G
    Tolazzi, G
    Quadrifoglio, F
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1999, 9 (03): : 261 - 270
  • [24] PHOSPHONOLIPIDS .27. SYNTHESIS OF O-(2-AMINOETHYL)PHOSPHONO-L-SERINE AND ITS STEREOISOMER
    BAER, E
    EBER, JT
    CANADIAN JOURNAL OF BIOCHEMISTRY, 1974, 52 (08): : 718 - 722
  • [25] Chain-length effects on helix-forming tendency in sequential peptides containing 2-dehydrophenylalanine residues
    Inai, Y
    Hasegawa, K
    Hirabayashi, T
    Yokota, K
    POLYMER JOURNAL, 1996, 28 (05) : 440 - 445
  • [26] Synthesis and properties of triple helix-forming oligodeoxyribonucleotides containing 7-chloro-7-deaza-2′-deoxyguanosine
    Aubert, Y
    Perrouault, L
    Hélène, C
    Giovannangeli, C
    Asseline, U
    BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (06) : 1617 - 1624
  • [27] Temporary ex vivo inhibition of the expression of the human oncogene HER2(NEU) by a triple helix-forming oligonucleotide
    Porumb, H
    Gousset, H
    Letellier, R
    Salle, V
    Briane, D
    Vassy, J
    AmorGueret, M
    Israel, L
    Taillandier, E
    CANCER RESEARCH, 1996, 56 (03) : 515 - 522
  • [28] Use of triple helix-forming oligodeoxynucleotides as a novel therapeutic strategy for erb-B2 positive breast cancer
    Dolan, C
    Wogan, A
    Hollywood, D
    McCann, SR
    Lawler, M
    BRITISH JOURNAL OF CANCER, 1998, 78 : 31 - 31
  • [29] Novel 2′-deoxycytidine analogues as pH independent substitutes of protonated cytosines in triple helix forming oligonucleotides
    Bédu, E
    Benhida, R
    Devys, M
    Fourrey, JL
    TETRAHEDRON LETTERS, 1999, 40 (05) : 835 - 838
  • [30] Syntheses of Biologically Non-Toxic ZnS:Mn Nanocrystals by Surface Capping with O-(2-aminoethyl)polyethylene Glycol and O-(2-carboxyethyl)polyethylene Glycol Molecules
    Kong, Hoon-Young
    Song, Byung-Kwan
    Byun, Jonghoe
    Hwang, Cheong-Soo
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2013, 34 (04) : 1181 - 1187